Printer Friendly
The Free Library
14,701,750 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

National Antibiotic Resistance Monitoring System for Enteric Bacteria.


National Antibiotic Resistance Monitoring System (NARMS)--enteric bacteria is a collaboration by the Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center.  (CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
), the U.S. Food and Drug Administration, the Center for Veterinary Medicine Center for Veterinary Medicine

regulates the manufacture and distribution of food additives and drugs that will be given to animals. These include animals from which human foods are derived, as well as food additives and drugs for pet (or companion) animals.
 (FDA-CVM), and the U.S. Department of Agriculture, Agricultural Research Services (USDA-ARS USDA-ARS United States Department of Agriculture-Agricultural Research Service ). NARMS was established in 1996 and monitors antimicrobial drug resistance in Campylobacter Campylobacter

Genus of gram-negative spiral-shaped bacteria infecting mammals. Many species, especially C. fetus, cause miscarriage in sheep and cattle. C. jejuni is a common cause of food poisoning. Sources include meats (particularly chicken) and unpasteurized milk.
, Escherichia coli O157:H7, Enterococcus, non-Typhi Salmonella, Salmonella Typhi, and Shigella.

The 2004 meeting was held March 4-5 in Decatur, Georgia, and hosted by the Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic mycotic /my·cot·ic/ (mi-kot´ik)
1. pertaining to mycosis.

2. caused by a fungus.


my·cot·ic
adj.
1. Relating to mycosis.

2.
 Diseases, National Center for Infectious Diseases, CDC. The meeting highlighted data from scientific studies and surveillance for antimicrobial drug resistance in the United States and abroad with enteric bacteria isolated from humans, animals, and retail foods. Approximately 180 participants from 14 countries, representing 71 organizations, attended the meeting. The organizations included international and national public health agencies, state and local health departments, public health laboratories, industry consumer groups, and academic institutions from Australia, Canada, Cameroon, China, Denmark, Europe, Italy, Japan, Philippines, Poland, Thailand, the United Kingdom, the United States, and Vietnam.

The meeting began with a World Health Organization expert's summarization of a recent workshop on nonhuman antimicrobial drug use and antimicrobial drug resistance. Scientific assessment and risk management of antimicrobial drug use in agriculture and human and veterinary medicine were examined. A plenary session on the human health consequences of antimicrobial drug resistance consisted of two presentations from the United States and two presentations from Denmark.

The results of a study conducted by CDC that found higher rates of hospitalization and death in resistant Salmonella infection, as compared to susceptible ones, were presented. The results of another CDC study that found higher frequencies of bloodstream infection and hospitalization with resistant Salmonella infections, as compared to susceptible ones, were presented. A presentation from the Statens Serum Institut Statens Serum Institut (English: the State Serum Institute), or SSI for short, is a Danish sector research institute located on the island of Amager in Copenhagen.  in Denmark highlighted the association between flouroquinolone-resistant Campylobacter infections, as compared to susceptible ones, and a higher frequency of invasive illness, hospitalization, and death. A second presentation demonstrated increased death rates in resistant S. Typhimurium infections, as compared to susceptible ones. Other speakers highlighted emerging resistance to clinically important antimicrobial drugs, environmental studies on antimicrobial drug resistance, antimicrobial drug resistance in commensal commensal /com·men·sal/ (kom-men´sil)
1. living on or within another organism, and deriving benefit without harming or benefiting the host.

2. a parasite that causes no harm to the host.
 bacteria, partner perspectives on antimicrobial drug resistance, international perspectives on antimicrobial drug resistance, and NARMS educational activities. A presentation of the "GET SMART: Know When Antibiotics Work on the Farm" campaign highlighted educational efforts to promote the appropriate use of antibiotics in veterinary medicine. The campaign currently includes an interactive Web-based program on aspects of microbiology, pharmacology, infectious disease, and public health for veterinary students and veterinarians who participate in continuing education programs. The conference also included brief summaries of three recent outbreaks of multidrug-resistant S. Typhimurium DTI Diffusion tensor imaging (DTI)
A refinement of magnetic resonance imaging that allows the doctor to measure the flow of water and track the pathways of white matter in the brain.
04 Rtype, which has become a common strain of Salmonella isolated from humans and was resistant to ampicillin ampicillin (ăm'pĭsĭl`ĭn), a penicillin-type antibiotic that is effective against both gram-negative microorganisms and gram-positive microorganisms such as Escherichia coli. , chloramphenicol chloramphenicol (klōr'ămfĕn`əkŏl'), antibiotic effective against a wide range of gram-negative and gram-positive bacteria (see Gram's stain). It was originally isolated from a species of Streptomyces bacteria. , streptomycin, sulphonamides, and tetracyclines. More information about NARMS and antimicrobial resistance can be found at www.cdc.gov/NARMS.

Address for correspondence: Tom M. Chiller, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop D63, Atlanta, GA 30333, USA; fax: 404-371-5444; email: tnc@cdc.gov

Cheri N. Holmes * and Tom M. Chiller *

* Centers for Disease Control and Prevention, Atlanta, Georgia, USA
COPYRIGHT 2004 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Conference Summary
Author:Chiller, Tom M.
Publication:Emerging Infectious Diseases
Geographic Code:1USA
Date:Nov 1, 2004
Words:539
Previous Article:Vaccines: Preventing Disease Protecting Health.(Book Review)
Next Article:Scientific discovery and women's health.(About The Cover)(Cover Story)
Topics:



Related Articles
Keeping Bugs from Pumping Drugs.(fighting antibiotic-resistant strains)
Antibiotic Resistance in Escherichia coli from Nigerian Students, 1986-1998.(Statistical Data Included)
Drug-Resistant Salmonella enterica Serotype Paratyphi A in India.(Statistical Data Included)
Genotypic Analysis of Multidrug-Resistant Salmonella enterica Serovar Typhi, Kenya.
Antibiotic resistance is coming to dinner.(Brief Article)
Enteric Fever Treatment Failures: A Global Concern.
Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. (Research).(Statistical Data Included)
Practical stuff!(Statistical Data Included)(Brief Article)
Multiply resistant (MR) Salmonella enterica serotype Typhimurium DT 12 and DT 120: a case of MR DT 104 in disguise? (Dispatches).
The potential role of concentrated animal feeding operations in infectious disease epidemics and antibiotic resistance.(Mini-Monograph)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles